outline and evaluate drug therapies for schizophrenia Flashcards
outline typical anti-psychotics
first gen - 1950s chlorpromazine
work of principles off original dopamine hypothesis so, chlorpromazine works by acting as a dopamine antagonist
dopamine antagonist - drug that binds to dopamine receptor to block its action & reduce levels of dopamine reaching post synaptic neuron
bind to d2 receptors to prevent too much dopamine being absorbed by d2 receptors
normalises neurotransmission in key areas of the brain, reducing positive symptoms of schizophrenia such as hallucinations
outline atypical anti-psychotics
2nd gen - 1980/1990s clozpine and risperidone
clozapine developed in 1960s and first trialled in 1970s
suggested to be more effective than typical anti-psychotics as it binds to receptors as chlorpromazine does but also acts on serotonin and glutamate receptors, treating both positive and negative symptoms
risperidone developed in 1990s as clozapine was involved in deaths from agranulocytosis
binds to dopamine and serotonin receptors
however, risperidone binds more strongly to dopamine receptors and is therefore more effective in smaller and has fewer side effects.
strength 1
supporting research evidence for typical
thornley et al 2003
reviewed data from 13 trials and found that chlorpromazine was associated with better functioning and reduced symptom severity compared to a placebo
strengthens biological treatments of schizophrenia as typical anti-psychotics help schizophrenic patients in minimising their symptoms to enhance their quality of life
strength 2
supporting research evidence atypical anti-psychotics are effective
meltzer et al 2012
concluded that clozapine is more effective in 30-50% of treatment resistant cases where typical anti-psychotics have failed
suggests atypical anti-psychotics are more effective than typical in treatment of schizophrenia, meaning clozapine may be a better drug treatment
limit 1
is that other treatments may be more clinically successful
this is because anti-psychotics only reduce schizophrenic symptoms rather than tackling the underlying cause
e.g. if a patient stops taking their medication, their schizophrenia symptoms may reappear resulting in the patient becoming reliant on the drug to function normally
suggests psychological therapies, such as CBT, which tackle the underlying causes of schizophrenia are more successful than drug therapies
psychology +
some would argue drug treatments of schizophrenia are still more effective than psychological treatments as they are more cost effective
e.g. they do not require a trained psychologist
ensure patients can return to work quicker, and minimise the burden on the NHS